These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Disability in patients with Menière's disease following the use of two different treatment modalities: betahistine and intratympanic gentamicin. Enrique-Gonzaleza A, Sánchez-Ferrándiz N, Pérez-Fernández N. Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):249-54. PubMed ID: 19408504 [Abstract] [Full Text] [Related]
5. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes. Smith WK, Sandooram D, Prinsley PR. J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921 [Abstract] [Full Text] [Related]
9. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss. Derebery MJ, Fisher LM, Berliner K, Chung J, Green K. Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498 [Abstract] [Full Text] [Related]
10. [Intratympanic gentamicin treatment for intractable Menière's disease]. Gilony D, Wolf M, Kronenberg J. Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278 [Abstract] [Full Text] [Related]